檢索結果 - Christopher Stroh

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
    Death by a thousand cuts: an ever increasing list of caspase substrates

    Death by a thousand cuts: an ever increasing list of caspase substrates 由 Christopher Stroh, Klaus Schulze‐Osthoff

    出版 1998
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Unique and overlapping substrate specificities of caspase-8 and caspase-10

    Unique and overlapping substrate specificities of caspase-8 and caspase-10 由 Ute Fischer, Christopher Stroh, Klaus Schulze‐Osthoff

    出版 2005
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    P2X7/P2Z Purinoreceptor-mediated Activation of Transcription Factor NFAT in Microglial Cells

    P2X7/P2Z Purinoreceptor-mediated Activation of Transcription Factor NFAT in Microglial Cells 由 Davide Ferrari, Christopher Stroh, Klaus Schulze‐Osthoff

    出版 1999
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping

    The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping 由 Ravi Salgia, Martin Sattler, Juergen Scheele, Christopher Stroh, Enriqueta Felip

    出版 2020
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design

    Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design 由 Marek Łoś, Małgorzata Burek, Christopher Stroh, Konrad Benedyk, Hubert Hug, Andrzej Maćkiewicz

    出版 2003
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    Caspases: more than just killers?

    Caspases: more than just killers? 由 Marek Łoś, Christopher Stroh, Reiner U. Jänicke, Ingo H. Engels, Klaus Schulze‐Osthoff

    出版 2001
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  7. 7
    The role of caspases in cryoinjury: caspase inhibition strongly improves the recovery of cryopreserved hematopoietic and other cells

    The role of caspases in cryoinjury: caspase inhibition strongly improves the recovery of cryopreserved hematopoietic and other cells 由 Christopher Stroh, U. Cassens, Ajoy Kumar Samraj, Walter Sibrowski, Klaus Schulze‐Osthoff, Marek Łoś

    出版 2002
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Patients with advanced non-small cell lung cancer harboring MET alterations: A descriptive cohort study

    Patients with advanced non-small cell lung cancer harboring MET alterations: A descriptive cohort study 由 Alexis B. Cortot, Emmanuelle Boutmy, Yuexi Wang, Christopher Stroh, Andreas Johne, Alnecia R Nisbett, Alex B. Ryder

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Liquid and tissue biopsies for identifying MET exon 14 skipping NSCLC: Analyses from the Phase II VISION study of tepotinib

    Liquid and tissue biopsies for identifying MET exon 14 skipping NSCLC: Analyses from the Phase II VISION study of tepotinib 由 Christian Rolfo, Aurora O’Brate, Christoph Menzel, Rolf Bruns, Dilafruz Juraeva, Christopher Stroh, Andreas Johne, Paul K. Paik

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Activation and Caspase-mediated Inhibition of PARP: A Molecular Switch between Fibroblast Necrosis and Apoptosis in Death Receptor Signaling

    Activation and Caspase-mediated Inhibition of PARP: A Molecular Switch between Fibroblast Necrosis and Apoptosis in Death Receptor Signaling 由 Marek Łoś, Malgorzata Mozoluk, Davide Ferrari, Anna Stępczyńska, Christopher Stroh, Andrea Renz, Zdenko Herceg, Zhao‐Qi Wang, Klaus Schulze‐Osthoff

    出版 2002
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Agonists of Proteinase-Activated Receptor-2 Stimulate Upregulation of Intercellular Cell Adhesion Molecule-1 in Primary Human Keratinocytes via Activation of NF-kappa B

    Agonists of Proteinase-Activated Receptor-2 Stimulate Upregulation of Intercellular Cell Adhesion Molecule-1 in Primary Human Keratinocytes via Activation of NF-kappa B 由 Joerg Buddenkotte, Christopher Stroh, Ingo H. Engels, Corinna Moormann, Victoria Shpacovitch, Stephan Seeliger, Nathalie Vergnolle, Dietmar Vestweber, Thomas A. Luger, Klaus Schulze‐Osthoff, Martin Steinhoff

    出版 2005
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and <i>RAS</i> Mutations in Colorectal Cancer

    Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and <i>RAS</i> Mutations in Colorectal Cancer 由 Eric Van Cutsem, Heinz‐Josef Lenz, Claus-Henning Köhne, Volker Heinemann, Sabine Tejpar, I. Melezínek, Frank Beier, Christopher Stroh, Philippe Rougier, J. Han van Krieken, Fortunato Ciardiello

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer

    Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer 由 Carsten Bokemeyer, Igor Bondarenko, Anatoly Makhson, J. T. Hartmann, Jorge Aparicio, Filippo de Braud, S. Donea, Heinz Ludwig, Gunter Schuch, Christopher Stroh, Anja H. Loos, Angela Zubel, P. Koralewski

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study

    Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metasta... 由 Lisa Licitra, Ricard Mesı́a, Fernando Rivera, Éva Remenár, Ricardo Hitt, J. Erfán, Sylvie Rottey, Andrzej Kawecki, D. Zabolotnyy, Marco Benasso, Stephan Störkel, Stefanie Senger, Christopher Stroh, JB Vermorken

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Molecular Response to Cetuximab and Efficacy of Preoperative Cetuximab-Based Chemoradiation in Rectal Cancer

    Molecular Response to Cetuximab and Efficacy of Preoperative Cetuximab-Based Chemoradiation in Rectal Cancer 由 Annelies Debucquoy, Karin Haustermans, Anneleen Daemen, Selda Aydın, Louis Libbrecht, Olivier Gevaert, Bart De Moor, Sabine Tejpar, William H. McBride, Freddy Penninckx, Pierre Scalliet, Christopher Stroh, Soetkin Vlassak, Christine Sempoux, Jean‐Pascal Machiels

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Pharmacogenomic and Pharmacoproteomic Studies of Cetuximab in Metastatic Colorectal Cancer: Biomarker Analysis of a Phase I Dose-Escalation Study

    Pharmacogenomic and Pharmacoproteomic Studies of Cetuximab in Metastatic Colorectal Cancer: Biomarker Analysis of a Phase I Dose-Escalation Study 由 Josep Tabernero, Andrés Cervantes, Fernando Rivera, Erika Martinelli, Federico Rojo, Anja von Heydebreck, Teresa Macarulla, Edith Rodríguez-Braun, M. E. Vega-Villegas, Stefanie Senger, Francisco Javier Ramos, Susana Roselló, İlhan Çelik, Christopher Stroh, José Baselga, Fortunato Ciardiello

    出版 2010
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  17. 17
    Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

    Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer 由 Eric Van Cutsem, Claus-Henning Köhne, Erika Hitre, J. Załuski, Chung-Rong Chang Chien, Anatoly Makhson, Geert D’Haens, Tamás Pintér, Robert Lim, G. Bodoky, Jae Kyung Roh, Gunnar Folprecht, Paul Ruff, Christopher Stroh, Sabine Tejpar, Michael Schlichting, Johannes Nippgen, Philippe Rougier

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer

    The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer 由 Francisco Javier Sánchez-Martín, Beatríz Bellosillo, Mariona Gelabert‐Baldrich, Alba Dalmases, Israel Cañadas, Joana Vidal, Alejandro Martínez, Guillem Argilés, Giulia Siravegna, Sabrina Arena, Klaus Koefoed, Laura Visa, Oriol Arpí, Ivan D. Horak, Mar Iglesias, Christopher Stroh, Michael Kragh, Ana Rovira, Joan Albanell, Josep Tabernero, Alberto Bardelli, Clara Montagut

    出版 2016
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Tepotinib in Non–Small-Cell Lung Cancer with <i>MET</i> Exon 14 Skipping Mutations

    Tepotinib in Non–Small-Cell Lung Cancer with <i>MET</i> Exon 14 Skipping Mutations 由 Paul K. Paik, Enriqueta Felip, Rémi Veillon, Hiroshi Sakai, Alexis B. Cortot, Marina Chiara Garassino, Julien Mazières, Santiago Viteri, Hélène Senellart, Jan P. van Meerbeeck, Jo Raskin, Niels Reinmuth, Pierfranco Conté, Dariusz M. Kowalski, Byoung Chul Cho, Jyoti D. Patel, Leora Horn, Frank Griesinger, Ji‐Youn Han, Young‐Chul Kim, Gee‐Chen Chang, Chen‐Liang Tsai, James Chih‐Hsin Yang, Yuh-Min Chen, Egbert F. Smit, Anthonie J. van der Wekken, Terufumi Kato, Dilafruz Juraeva, Christopher Stroh, Rolf Bruns, Josef Straub, Andreas Johne, J. Scheele, John V. Heymach, Xiuning Le

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: